Security Snapshot

Beta Bionics, Inc. - Common Stock, $0.0001 par value per share (BBNX) Institutional Ownership

CUSIP: 08659B102

13F Institutional Holders and Ownership History from Q1 2025 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

104

Shares (Excl. Options)

38.24MFull value: 38,242,399 · shares · 30 Sep 2026

Price

$18.98

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-3,082,375
Value change
-$45,600,587
Number of holders
104
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
53,730,222
SEC-reported price per share
$17.58
Insider filing price
$17.58
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • BBNX - Beta Bionics, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 08659B102.
  • 104 institutions reported positions in Q3 2026.
  • 15 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 131 to 104 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $752.39MFull value: $752,391,092 · USD · 30 Jun 2026
    to
    $726.03MFull value: $726,034,263 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 104 institutions filings for Q3 2026.

Open SEC evidence

Security key

08659B102

13F reference period

Q3 2026

13F holders

104

13D/G owners

15

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
15
Security
BBNX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRICE T ROWE ASSOCIATES INC /MD/ 17% $169,741,981 8,943,061 T. Rowe Price Associates, Inc. 30 Sep 2026
EVENTIDE ASSET MANAGEMENT, LLC 13% +19% $52,677,024 +$9,643,640 5,945,488 +22% Eventide Asset Management, LLC 31 Mar 2026
Soleus Capital Master Fund, L.P. 8.7% $91,550,616 4,828,619 Levy Guy 30 Sep 2026
Soleus Capital Group, LLC 9.8% $38,580,879 4,354,501 Levy Guy 31 Mar 2026
Zone Healthcare Holdings, LLC 9.9% +25% $85,717,590 +$17,618,729 4,313,920 +26% Dapice Joshua J. 30 Sep 2025
MORGAN STANLEY 8.6% +26% $74,305,196 +$16,109,185 3,739,567 +28% Morgan Stanley 30 Sep 2025
Farallon Capital Partners, L.P. 8.1% -18% $31,966,171 -$6,839,920 3,607,920 -18% Dapice Joshua J. 31 Mar 2026
Sands Capital Life Sciences Pulse Fund II, L.P. 8.2% +13% $48,410,732 +$5,636,946 3,570,113 +13% Sands Capital Life Sciences Pulse Fund II. L.P. 30 Jun 2025
BlackRock, Inc. 6.4% $55,215,708 2,778,764 BlackRock, Inc. 30 Sep 2025
RTW INVESTMENTS, LP 4.5% -20% $17,720,000 -$4,430,000 2,000,000 -20% RTW Investments, LP 31 Mar 2026
PERCEPTIVE ADVISORS LLC 3.7% $21,609,324 1,593,608 Perceptive Advisors LLC 31 Mar 2025
Point72 Asset Management, L.P. 1.8% -68% $18,337,050 -$25,081,786 967,144 -58% Point72 Asset Management, L.P. 30 Sep 2026
MILLENNIUM MANAGEMENT LLC 1.8% -70% $15,835,993 -$29,602,207 796,964 -65% Millennium Management LLC 30 Sep 2025
FARALLON CAPITAL MANAGEMENT, L.L.C. 1.3% $9,948,400 595,000 Farallon Capital Management, L.L.C. 30 Jun 2026
Divisadero Street Capital Management, LP 0.1% -97% $1,220,808 -$52,802,268 69,443 -98% Divisadero Street Capital Management, LP 30 Sep 2026
As of 30 Sep 2026, 104 institutional investors reported holding
38.24MFull value: 38,242,399 · shares · 30 Sep 2026
shares of Beta Bionics, Inc. - Common Stock, $0.0001 par value per share (BBNX). This represents 71% of the company’s total
53.73MFull value: 53,730,222 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
58%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
EVENTIDE ASSET MANAGEMENT, LLC 13% 7,044,630 1.9% $133,724,910
Sands Capital Alternatives, LLC 7.4% 3,997,898 11% $75,880,104
Soleus Capital Management, L.P. 7% 3,743,714 2.5% $71,055,692
VANGUARD CAPITAL MANAGEMENT LLC 4.2% 2,238,975 0% $42,495,746
DEERFIELD MANAGEMENT COMPANY, L.P. 3.5% 1,903,710 0.56% $36,132,416
GEODE CAPITAL MANAGEMENT, LLC 2.1% 1,137,313 0% $21,591,669
First Light Asset Management, LLC 2.1% 1,109,420 1.2% $21,056,792
Eversept Partners, LP 1.9% 1,023,872 1.1% $19,433,091
STATE STREET CORP 1.9% 1,020,778 0% $19,374,366
RTW INVESTMENTS, LP 1.9% 998,855 0.19% $18,958,268
Point72 Asset Management, L.P. 1.8% 967,144 0.03% $18,356,393
Omega Fund Management, LLC 1.8% 962,010 15% $18,258,950
BANK OF AMERICA CORP /DE/ 1.6% 867,059 0% $16,456,779
Bruce & Co., Inc. 1.2% 665,700 3.4% $12,634,986
PERCEPTIVE ADVISORS LLC 1% 538,159 0.19% $10,214,258
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 0.93% 500,000 0.31% $9,490,000
TD ASSET MANAGEMENT INC 0.73% 392,422 0.01% $7,616,911
Trexquant Investment LP 0.68% 364,455 0.04% $6,917,356
VANGUARD FIDUCIARY TRUST CO 0.56% 302,929 0% $5,749,592
GOLDMAN SACHS GROUP INC 0.55% 293,837 0% $5,577,026
VANGUARD PORTFOLIO MANAGEMENT LLC 0.52% 277,941 0% $5,275,320
ING GROEP NV 0.47% 250,000 0.03% $4,745,000
MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.42% 227,831 0% $4,324,232
Mariner, LLC 0.41% 222,498 0% $4,223,013
Invesco Ltd. 0.39% 208,231 0% $3,952,225

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
7
Headline period
Q3 2026
Rows shown
1-7 of 7
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 38,242,399 $726,034,263 -$45,600,587 $18.98 104
2026 Q2 47,971,336 $752,391,092 -$13,915,230 $15.67 131
2026 Q1 49,288,407 $493,788,078 -$73,044,020 $10.02 128
2025 Q4 47,221,349 $1,439,223,888 +$22,363,225 $30.47 159
2025 Q3 48,310,134 $959,915,542 +$85,339,869 $19.87 127
2025 Q2 44,848,348 $652,883,600 +$53,846,940 $14.56 114
2025 Q1 41,702,710 $507,967,865 +$504,374,335 $12.24 102
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .